Jennifer Schneider Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Jennifer Schneider is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 922 shares of VRTX, which is worth approximately $447,621. The most recent transaction as insider was on May 15, 2024, when has been sold 922 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 922

0% 3M change

n/a 12M change

Total Value Held $447,621

Jennifer Schneider Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 15 2024	BUY Grant, award, or other acquisition	-	922 Added 50.0%	922 Common Stock

Also insider at

LVGO

Livongo Health, Inc.

President